Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Endocrine Test Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026" ...
Please provide your email address to receive an email when new articles are posted on . An assessment of free cortisol after a dexamethasone suppression test could add value to the diagnostic workup ...
A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer. Results from the Breast Cancer Index (BCI) test led ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended endocrine therapy decisions for ...
Please provide your email address to receive an email when new articles are posted on . Symptoms associated with menstruation look different for every woman, and surgical options are available for ...
Status of Endocrine Disruptor Screening Program (EDSP) Test Orders/Data Call-Ins Status of other scientifically relevant information for EDSP: Submissions from recipients of EDSP orders and EPA ...
Peripheral neuropathy is commonly associated with diabetes mellitus. Early detection of nerve damage could help to prevent the development of pain and foot ulceration. The authors compared the ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., announced newly published data in JAMA Network Open showing that Breast Cancer Index® (BCI®) test results led physicians to change their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results